- ETST partners with Iq2 to develop food supplement designed to improve brain function
- Clinched deal with Forzagen to distribute cannabinoid product line in Mexico and South America
- Developing CBD beverage to tap $12 billion market
Earth Science Tech Inc. (OTCQB: ETST) has done it again. In partnership with Iq2 Labs, the Florida-based biotechnology company is formulating a super food supplement designed to enhance brain function through an initiative that continues the ongoing drive to strengthen its position in the hemp-derived cannabinoid, nutraceutical, pharmaceutical and medical device markets (http://cnw.fm/eS7QJ). The product, containing high-grade full-spectrum cannabinoids, is currently going through the package design process, after which it will be bottled, launched and plugged into ETST’s growing sales channels. The announcement by ETST comes on the heels of another: ETST has clinched a deal with premium dietary supplement provider Forzagen to distribute ETST’s line of cannabinoids throughout Mexico and South America (http://cnw.fm/32oM0).
The partnership with Iq2 Labs and the introduction of the brain-boosting supplement – CBD Mental Clarity and Focus Shot – give ETST a foothold in the emerging CBD beverage market, according to Nickolas S. Tabraue, chairman of ETST. The high-grade full-spectrum cannabinoids produced in conjunction with Iq2 are expected to be an accretive addition to ETST’s line of products aiming to augment mental capacity and function. The company’s researchers continue their efforts to develop a CBD beverage utilizing the University of Central Oklahoma’s provisional patent to improve immune system functions (http://cnw.fm/isGB2). An aspect of ETST’s marketing strategy focuses on increasing the ways it can deliver its CBD products to the marketplace. The collaboration with the University of Central Oklahoma, under the direction of Dr. Michel Aube, chief science officer of ETST, forms part of this plan.
Under a sponsored research agreement with the University of Central Oklahoma, tests were carried out to determine the effects of ETST’s CBD Cannabidiol Rich Hemp Oil on immune cells. The results were encouraging (http://cnw.fm/lCbm5). Research showed that ETST’s hemp oil solution, used in appropriate CBD concentrations, could, through the production of Tumor Necrosis Factor alpha (TNFα), stimulate macrophages, an important immune cell. The cytokine TNFα is a key cell signaler in the recruitment of immune cells. A robust immune system plays an important part in maintaining good health and may help fight cancer. There is now hope that the effects of hemp oil enriched with CBD on immune cells may be used to improve cancer treatment, particularly in combination with other treatment modalities. The proposed beverage will allow ETST to tap into the $11.7 billion (2018 estimate) CBD beverage market, which is projected to hit $25 billion by 2025.
With the establishment of these partnerships in 2019, ETST sustains the relentless path of growth put into place in 2018, when it doubled sales. ETST also uplisted to the OTCQB Venture Market and introduced a new product, Hygee, a non-invasive discreet chlamydia testing kit. The company continues to disrupt the hemp-derived cannabinoid, nutraceutical, pharmaceutical and medical device markets. Its activities range from R&D to production to marketing and distribution. ETST plans to keep building the networks and infrastructure to launch new subsidiaries and new products, like its super supplement to boost brainpower.
For more information, visit the company’s website at www.EarthScienceTech.com
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
